Bellicum Pharmaceuticals

Curevo Vaccine

Curevo Vaccine is a privately held, clinical-stage biotechnology company based near Seattle and dedicated to reducing the burden of infectious disease by developing safe and highly effective vaccines via its sub-unit vaccine technology platform. Its lead product is CRV-101, a sub-unit vaccine to prevent the reactivation of the varicella zoster virus (shingles) in older adults.